Trial Profile

Early Copper Histidine Therapy in Menkes Disease

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 28 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Copper histidinate (Primary)
Indications Menkes kinky hair syndrome
Focus Registrational; Therapeutic Use

Most Recent Events

21 Mar 2022 According to a Fortress Biotech media release, data from this study will be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting.
08 Oct 2021 According to a Cyprium Therapeutics media release, data (n=129) from this study were presented at the virtual poster at the 2021 American Academy of Pediatrics National Conference & Exhibition.
08 Oct 2021 Results presented in a Cyprium Therapeutics media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com